azathioprine has been researched along with Epidermolysis Bullosa in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Epidermolysis Bullosa: Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furue, M | 1 |
| Iwata, M | 1 |
| Yoon, HI | 1 |
| Kubota, Y | 1 |
| Ohto, H | 1 |
| Kawashima, M | 1 |
| Tsuchida, T | 1 |
| Oohara, K | 1 |
| Tamaki, K | 1 |
| Kukita, A | 1 |
1 other study available for azathioprine and Epidermolysis Bullosa
| Article | Year |
|---|---|
Epidermolysis bullosa acquisita: clinical response to plasma exchange therapy and circulating anti-basement membrane zone antibody titer.
Topics: Autoantibodies; Azathioprine; Basement Membrane; Betamethasone; Cyclophosphamide; Dapsone; Epidermol | 1986 |